Shanghai ZJ Bio-Tech Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai ZJ Bio-Tech Co., Ltd.

Why is Shanghai ZJ Bio-Tech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -38.37% and Operating profit at -179.56% over the last 5 years

The company has declared Negative results for the last 11 consecutive quarters

NET PROFIT(9M) At CNY -29.38 MM has Grown at -125.82%
NET SALES(Q) At CNY 30.75 MM has Fallen at -28.46%
INTEREST(Q) Highest at CNY 1.1 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 15.10%, its profits have fallen by -14.6%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai ZJ Bio-Tech Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shanghai ZJ Bio-Tech Co., Ltd.

15.5%

0.78

48.22%

China Shanghai Composite

20.36%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-38.37%

EBIT Growth (5y)

-179.56%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.76

Sales to Capital Employed (avg)

0.05

Tax Ratio

13.69%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

69.93%

ROE (avg)

12.09%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.13

EV to EBIT

-4.56

EV to EBITDA

-5.45

EV to Capital Employed

1.55

EV to Sales

9.15

PEG Ratio

Dividend Yield

ROCE (Latest)

-33.94%

ROE (Latest)

-4.24%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

NET PROFIT(HY)

Higher at CNY -32.99 MM

ROCE(HY)

Highest at -1.28%

INVENTORY TURNOVER RATIO(HY)

Highest at 1.79 times

DEBTORS TURNOVER RATIO(HY)

Highest at 2.72 times

RAW MATERIAL COST(Y)

Fallen by -225.31% (YoY

-33What is not working for the Company

INTEREST(HY)

At CNY 2.83 MM has Grown at 423.69%

OPERATING CASH FLOW(Y)

Lowest at CNY 61.19 MM

NET SALES(Q)

Lowest at CNY 25.42 MM

OPERATING PROFIT(Q)

Lowest at CNY -16.49 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -64.88 %

PRE-TAX PROFIT(Q)

Lowest at CNY -24.1 MM

NET PROFIT(Q)

Lowest at CNY -25.71 MM

EPS(Q)

Lowest at CNY -0.15

Here's what is working for Shanghai ZJ Bio-Tech Co., Ltd.

Inventory Turnover Ratio

Highest at 1.79 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 2.72 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -225.31% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai ZJ Bio-Tech Co., Ltd.

Interest

At CNY 2.83 MM has Grown at 423.69%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 25.42 MM has Fallen at -20.9%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY -24.1 MM has Fallen at -56.3%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -25.71 MM has Fallen at -60.54%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 61.19 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 25.42 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY -16.49 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -64.88 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY -24.1 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY -25.71 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY -0.15

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)